Modern cancer therapy has significantly improved cancer survival, transforming several once-fatal cancers into chronic disease, but often at the expense of exposure to cardiotoxic drugs. Cardiovascular disease is now a leading cause of morbidity and mortality in cancer survivors as they are living long enough to experience later onset cardiac effects of these treatments. Cardio-oncology is a rapidly evolving field comprised of multidisciplinary care teams focused on improving the outcome of patients with cancer.

The purpose of this conference is to provide a state-of-the-art, comprehensive, case-based curriculum that addresses important clinical topics relevant to the cardiovascular health of patients with cancer. Clinical experts from Memorial Sloan Kettering Cancer Center and around the country will present an up-to-date overview on cutting edge cancer therapies and best practice strategies in cardiovascular care in cancer patients including preventive strategies, early diagnosis and treatment and long-term surveillance. All presentations will include devoted time for interaction between audience members and presenters.